Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Manente, A G ^a   Valenti, D ^b   Pinton, G ^a   Jithesh, P V ^c   Daga, A ^d   Rossi, L ^e   Gray, S G ^f   O'Byrne, K J ^f   Fennell, D A ^g   Vacca, R A ^b   Nilsson, S ^h,i   Mutti, L ^j   Moro, L ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f ST JAMES S HOSPITAL   (Ireland)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

^h Karo Bio   (Sweden)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j SANT'ANDREA HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; ESTROGEN RECEPTOR BETA; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE B; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

EID: 84884944754     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.32     Document Type: Article

References (54)

1. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82: 4258-4265
2. Gustafsson JÅ. Estrogen receptor beta-getting in on the action? Nat Med 1997; 3: 493-494
3. Mancuso M, Leonardi S, Giardullo P, Pasquali E, Borra F, Stefano ID et al. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways. Cancer Lett 2011; 308: 197-202
4. Nilsson S, Gustafsson JÅ. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011; 89: 44-55, Review
5. Sareddy GR, Nair BC, Gonugunta VK, Zhang QG, Brenner A, Brann DW et al. Therapeutic significance of estrogen receptor b agonists in gliomas. Mol Cancer Ther 2012; 5: 1174-1182
6. Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA. Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor b-selective ligands. J Med Chem 2012; 55: 528-537
7. Hughes ZA, Liu F, Platt BJ, Dwyer JM, Pulicicchio CM, Zhang G et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/ antidepressant agent. Neuropharmacology 2008; 54: 1136-1142
8. Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor b ligands: recent advances and biomedical applications. Med Res Rev 2011; 31: 364-442
9. Muthusamy S, Andersson S, Kim HJ, Butler R, Waage L, Bergerheim U et al. Estrogen receptor b and 17b-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer. Proc Natl Acad Sci USA 2011; 108: 20090-20094
10. Nilsson S, Koehler KF, Gustafsson JÅ. Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 2011; 10: 778-792, Review
11. Parker Jr DL, Meng D, Ratcliffe RW, Wilkening RR, Sperbeck DM, Greenlee ML et al. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists. Bioorg Med Chem Lett 2006; 16: 4652-4656
12. Weiser MJ, Wu TJ, Handa RJ. Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R-and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009; 150: 1817-1825
13. Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML et al. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands. Bioorg Med Chem Lett 2006; 16: 3489-3494
14. Marzioni M, Torrice A, Saccomanno S, Rychlicki C, Agostinelli L, Pierantelli I et al. An oestrogen receptor b-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. Dig Liver Dis 2012; 44: 134-142
15. Yakimchuk K, Iravani M, Hasni MS, Rhonnstad P, Nilsson S, Jondal M et al. Effect of ligand-activated estrogen receptor b on lymphoma growth in vitro and in vivo. Leukemia 2011; 25: 1103-1110
16. Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA et al. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Cancer Res 2009; 69: 4598-4604
17. Pinton G, Thomas W, Bellini P, Manente AG, Favoni RE, Harvey BJ et al. Estrogen receptor b exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib. PLoS One 2010; 5: e14110
18. Campbell NP, Kindler HL. Update on malignant pleural mesothelioma. Semin Respir Crit Care Med 2011; 32: 102-110, Review
19. Kazan-Allen L. Asbestos and mesothelioma: worldwide trends. Lung Cancer 2005; 49: S3-S8
20. Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 2010; 107: 12611-12616
21. Kaufman AJ, Pass HI. Current concepts in malignant pleural mesothelioma. Exp Rev Anticancer Ther 2008; 8: 293-303, Review
22. Tsiouris A, Walesby RK. Malignant pleural mesothelioma: current concepts in treatment. Nat Clin Pract Oncol 2007; 4: 344-352, Review
23. Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. European Respiratory Society/European Society of Thoracic Surgeons Task Force. Eur Respir J 2010; 35: 479-495
24. Blayney JK, Ceresoli GL, Castagneto B, O'Brien ME, Hasan B, Sylvester R et al. Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. Eur J Cancer 2012; 48: 2983-2992
25. Ray M, Kindler HL. Malignant pleural mesothelioma: an update on biomarkers and treatment. Chest 2009; 136: 888-896, Review
26. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-1603
27. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033, Review
28. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-337Review
29. Gruning NM, Lehrach H, Ralser M. Regulatory crosstalk of the metabolic network. Trends Biochem Sci 2010; 35: 220-227, Review
30. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472-482
31. Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 2011; 1807: 552-561
32. Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2011; 2: 49
33. Drose S, Bleier L, Brandt U. A common mechanism links differently acting complex II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen species production. Mol Pharmacol 2011; 79: 814-822
34. Hargreaves IP, Duncan AJ, Wu L, Agrawal A, Land JM, Heales SJ. Inhibition of mitochondrial complex IV leads to secondary loss complex II-III activity: implications for the pathogenesis and treatment of mitochondrial encephalomyopathies. Mitochondrion 2007; 7: 284-287
35. Benard G, Trian T, Bellance N, Berger P, Lavie J et al. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid Redox Signal 2012, epub ahead of print Apr 19: 350-365
36. Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chaindeficient mouse hearts. Proc Natl Acad Sci USA 2004; 101: 3136-3141
37. Michel S, Wanet A, De Pauw A, Rommelaere G, Arnould T, Renard P. Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J Cell Physiol 2011; 227: 2297-2310
38. Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 2008; 7: 110-120
39. Oyedotun KS, Lemire BD. The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. J Biol Chem 2004; 279: 9424-9431
40. Horváth R, Abicht A, Holinski-Feder E, Laner A, Gempel K, Prokisch H et al. Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 2006; 77: 74-76
41. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49-54
42. Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43: 668-672
43. Fornuskova D, Stiburek L, Wenchich L, Vinsova K, Hansikova H, Zeman J. Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b. Biochem. J 2010; 428: 363-374
44. Hayashi R. Expression and regulation of an estrogen-responsive gene, cytochrome c oxidase subunit 7a related polypeptide (COX7RP) in endometrial cancer. Saitama Ika Daigaku Zasshi 2004; 31: 199-206
45. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004; 61: 450-458
46. Hu Y, Lu W, Chen G, Wang P, Chen Z, Zhou Y et al. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res 2011; 22: 399-412
47. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ et al. Successful adenovirus mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg 1994; 57: 1395-1401
48. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA. A genomewide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 2008; 27: 1019-1032
49. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
50. Chen J, Kadlubar FF, Chen JZ. DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair. Nucleic Acids Res 2007; 35: 1377-1388
51. Valenti D, Manente GA, Moro L, Marra E, Vacca RA. Altered cAMP-dependent phosphorylation of mitochondrial complex I determines deficit of the complex activity and overproduction of reactive oxygen species by mitochondria in human skin fibroblasts with chromosome 21 trisomy. Biochem J 2011; 435: 679-688
52. Valenti D, Tullo A, Caratozzolo MF, Merafina RS, Scartezzini P, Marra E et al. Impairment of F1FO-ATPase, adenine nucleotide translocator, and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem J 2010; 431: 299-310
53. Chelli B, Lena A, Vanacore R, Da Pozzo E, Costa B, Rossi L et al. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem Pharmacol 2004; 1: 125-134
54. Maftah A, Petit JM, Ratinaud MH, Julien R. 10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem Biophys Res Commun 1989; 164: 185-190